Yasekwa ngo-2009, i-JYMed ngumboneleli wenkonzo ye-peptide ye-CRDMO ekhokelayo kunye nomvelisi we-API yegeneric e-China egxile ekudibaneni kwesiko, uphuhliso lwenkqubo, ubonelelo lwekliniki kunye norhwebo lwezinto ze-peptide. Inkampani iqeshe malunga ne-600+ FTEs, kunye neqela lolawulo eliphambili elenziwe ziingcali ezineminyaka engama-20 yamava kubuchwepheshe bepeptide. I-JYMed isebenza kwiziko elinye le-R&D kunye nezixhobo ezimbini ezinkulu zemveliso yeenjongo ezininzi, ezinomthamo we-peptide wokwenza iitoni ezininzi.
Njengenkampani egxile kubathengi, i-JYMed ibonelela ngophuhliso olubanzi lwe-peptide kunye neqonga loshishino elixhaswa ngaphaya kweminyaka engama-20 yobuchwephesha be-R&D kunye nezixhobo zangoku. Sihambisa iipeptides ezikumgangatho ophezulu ezilungiselelwe iimfuno zomthengi ngamnye.
I-JYMed inikezela ngepotfoliyo ebanzi yee-API ze-peptide ze-20, kuquka i-Semaglutide, i-Tirzepatide, i-Liraglutide, i-Degarelix, kunye ne-Oxytocin. Ezininzi kwezi, ezifana neSemaglutide kunye neTirzepatide, ziye zagqiba ngempumelelo ukubhalisa kunye nokuthengisa.
I-JYMed inikezela ngeqonga leCDMO elibanzi nelisebenzayo, elibonelela ngeenkonzo ezipheleleyo zepeptide kunye neemveliso ze-analog ye-peptide. Oku kubandakanya uphando kunye nokuveliswa kweepeptides zonyango, iipeptides zonyango lwezilwanyana, kunye nokunye.
I-JYMed ibonelela nge-peptides ye-cosmetic ekumgangatho ophezulu, imathiriyeli ekrwada, kunye nokwakheka kwe-OEM ukusuka kuphando ukuya kwibakala le-cGMP-zonke ziphantsi kolawulo olungqongqo lwekhwalithi. Iipeptide zethu zokwenziwa zixatyiswe ngokubanzi kukhuseleko lwazo, ubunyulu, kunye nokulula ukwenza ngokwezifiso.
I-JYMed ngumvelisi we-peptide wase-US ohlolwe yi-FDA osebenza ngokukhethekileyo kwiipeptide zokuthambisa, ii-peptide APIs, kunye neepeptides zesiko. Iimveliso zethu ezifakiweyo ziquka i-Semaglutide, i-Liraglutide, i-Tirzepatide, i-Oxytocin, i-GHK, i-GHK-Cu, i-Acetyl Hexapeptide-8, kunye nokunye. Ukuze ufunde ngakumbi, nceda uqhagamshelane nathi ku:
Email: jymed@jymedtech.com











I-JYMed Peptide iyavuya ukukumema kwi-Pharmaconex 2025, eyenzeka ngoSeptemba 1-3, 2025, kwi-Egypt International Exhibition Centre (EIEC) eCairo. Ukugubungela indawo yokubonisa i-12,000 + square metres, umcimbi uya kubamba ababonisi be-350 + kwaye kulindeleke ukuba ukhangele i-8,000 + professional ...

I-JYMed Peptide inovuyo ukukumema kwi-CPhI Korea 2025, eqhubeka ukusuka nge-26-28 ka-Agasti, 2025, kwi-COEX Convention & Exhibition Centre eSeoul. Ukuthatha i-15,000 square metres, umcimbi kulindeleke ukuba ubambe ngaphezu kwe-450 umbukiso kwaye wamkele iindwendwe ezingaphezu kwe-10,000 zeengcali. Ngo-2024...

Siyavuya ukujoyina iinkokheli zoshishino kwi-CPHI South East Asia 2025, okwenzeka ngoJulayi 16 ukuya kwi-18 e-MITEC e-Kuala Lumpur. Esi siganeko sithatha i-15,000 square metres kwaye siya kubonisa malunga nababonisi be-400. Ngaphezulu kwe-8,000 yeengcali ekulindeleke ukuba zizimase, kunye neesemina ezingama-60+ kunye neeforamu ...